Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma

AIM: To investigate the role of signal transduction and activation of transcription 4(STAT4) in the development and progression of human hepatocellular carcinoma(HCC).METHODS: Recent genetic investigations have identified that a genetic variant of STAT4 is associated with hepatitis b virus(Hb V)-rel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of gastroenterology : WJG 2015-04, Vol.21 (13), p.3983-3993
Hauptverfasser: Wang, Gang, Chen, Jia-Hui, Qiang, Yong, Wang, Dong-Zhi, Chen, Zhong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3993
container_issue 13
container_start_page 3983
container_title World journal of gastroenterology : WJG
container_volume 21
creator Wang, Gang
Chen, Jia-Hui
Qiang, Yong
Wang, Dong-Zhi
Chen, Zhong
description AIM: To investigate the role of signal transduction and activation of transcription 4(STAT4) in the development and progression of human hepatocellular carcinoma(HCC).METHODS: Recent genetic investigations have identified that a genetic variant of STAT4 is associated with hepatitis b virus(Hb V)-related HCC. The level of STAT4 in 90 HCC patients was examined via Western blot and immunohistochemical analyses. The correlation between STAT4 expression and the clinicopathological characteristics of the patients was analyzed. The level of STAT4 expression in the HCC liver tissues was significantly lower than that in the non-HCC liver tissues and correlated with tumor size, histological grade of HCC and serum hepatitis b surface antigen level in HCC patients. The data were statistically analyzed using SPSS. Furthermore, si RNA oligos targeting STAT4 were employed to investigate the influence of STAT4 RNA interference on HCC cell physiology. based on Cell Counting Kit-8 and flow cytometric assays, we found that depletion of STAT4 expression significantly enhanced the proliferation of L02 cells.RESULTS: STAT4 protein expression was significantly lower in HCC tissues than in normal liver tissues. Immunohistochemistry followed by statistical analysis revealed that the expression of STAT4 negatively correlated with Ki67 expression(r = 0.851; P < 0.05) and positively correlated with maximal tumor size(P < 0.05), Hb V(P = 0.012) and histological grade(P < 0.05). Kaplan-Meier analysis revealed significant differences in the survival curves between HCC patients expressing low and high levels of STAT4 and Ki67(P < 0.05). based on a multivariate Cox proportional hazard model, STAT4 expression was an independent prognostic indicator for HCC patients who underwent curative resection. In vitro, following the release of L02 cell lines from serum starvation, the expression of STAT4 was downregulated, and transfection of L02 cells with si RNA targeting STAT4 inhibited cell proliferation.CONCLUSION: Our data indicate that STAT4 may inhibit HCC development by modulating HCC cell proliferation.
doi_str_mv 10.3748/wjg.v21.i13.3983
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4385547</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>90888889504849534951485054</cqvip_id><sourcerecordid>1672090301</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-22d346c890a9a06d1de4fe130cc6ae60dfa37d5cfd2304bd5b54cdac09cb00523</originalsourceid><addsrcrecordid>eNpVkctvEzEQhy0EomnhzgntkcuG8WvXviBVLS-pEgfC2ZrY3o2rjZ3am1b893jVEIGlkQ-_hz36CHlHYc17oT4-3Y_rR0bXgfI114q_ICvGqG6ZEvCSrChA32rO-gtyWco9AONcstfkgkklGVNyRdytt9lj8a75ubneiCZEFyzOvjSHlHJzyGmMqYTSYHSNjzuMtnqtn6ZFm8LgM84hxRpsdv6Ac1q044S5sZhtiGmPb8irAafi357uK_Lry-fNzbf27sfX7zfXd60VAuaWMcdFZ5UG1Aido86LwVMO1nboO3AD8t5JOzjGQWyd3EphHVrQdgsgGb8in557D8ft3jvr45xxMocc9ph_m4TB_K_EsDNjejSCKylFXws-nApyejj6Mpt9KMs-GH06FkO7noEGDrRa4dlqcyol--H8DAWzwDEVjqlwTIVjFjg18v7f750Df2lUAz917lIcH0Iczx4NajlaglBCS16HCiVBCv4HCOGeWg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1672090301</pqid></control><display><type>article</type><title>Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma</title><source>MEDLINE</source><source>Baishideng "World Journal of" online journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Wang, Gang ; Chen, Jia-Hui ; Qiang, Yong ; Wang, Dong-Zhi ; Chen, Zhong</creator><creatorcontrib>Wang, Gang ; Chen, Jia-Hui ; Qiang, Yong ; Wang, Dong-Zhi ; Chen, Zhong</creatorcontrib><description>AIM: To investigate the role of signal transduction and activation of transcription 4(STAT4) in the development and progression of human hepatocellular carcinoma(HCC).METHODS: Recent genetic investigations have identified that a genetic variant of STAT4 is associated with hepatitis b virus(Hb V)-related HCC. The level of STAT4 in 90 HCC patients was examined via Western blot and immunohistochemical analyses. The correlation between STAT4 expression and the clinicopathological characteristics of the patients was analyzed. The level of STAT4 expression in the HCC liver tissues was significantly lower than that in the non-HCC liver tissues and correlated with tumor size, histological grade of HCC and serum hepatitis b surface antigen level in HCC patients. The data were statistically analyzed using SPSS. Furthermore, si RNA oligos targeting STAT4 were employed to investigate the influence of STAT4 RNA interference on HCC cell physiology. based on Cell Counting Kit-8 and flow cytometric assays, we found that depletion of STAT4 expression significantly enhanced the proliferation of L02 cells.RESULTS: STAT4 protein expression was significantly lower in HCC tissues than in normal liver tissues. Immunohistochemistry followed by statistical analysis revealed that the expression of STAT4 negatively correlated with Ki67 expression(r = 0.851; P &amp;lt; 0.05) and positively correlated with maximal tumor size(P &amp;lt; 0.05), Hb V(P = 0.012) and histological grade(P &amp;lt; 0.05). Kaplan-Meier analysis revealed significant differences in the survival curves between HCC patients expressing low and high levels of STAT4 and Ki67(P &amp;lt; 0.05). based on a multivariate Cox proportional hazard model, STAT4 expression was an independent prognostic indicator for HCC patients who underwent curative resection. In vitro, following the release of L02 cell lines from serum starvation, the expression of STAT4 was downregulated, and transfection of L02 cells with si RNA targeting STAT4 inhibited cell proliferation.CONCLUSION: Our data indicate that STAT4 may inhibit HCC development by modulating HCC cell proliferation.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v21.i13.3983</identifier><identifier>PMID: 25852285</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Inc</publisher><subject>activation ; Adult ; Aged ; and ; Biomarkers, Tumor - genetics ; Biomarkers, Tumor - metabolism ; Carcinoma, Hepatocellular - genetics ; Carcinoma, Hepatocellular - metabolism ; Carcinoma, Hepatocellular - mortality ; Carcinoma, Hepatocellular - pathology ; Cell Proliferation ; Chi-Square Distribution ; Clinical Trials Study ; Down-Regulation ; Female ; Gene Expression Regulation, Neoplastic ; Hep G2 Cells ; Humans ; Immunohistochemistry ; Kaplan-Meier Estimate ; Ki-67 Antigen - metabolism ; Liver Neoplasms - genetics ; Liver Neoplasms - metabolism ; Liver Neoplasms - mortality ; Liver Neoplasms - pathology ; Male ; Middle Aged ; Multivariate Analysis ; Neoplasm Grading ; Proportional Hazards Models ; Risk Factors ; RNA Interference ; Signal ; Signal Transduction ; STAT4 Transcription Factor - genetics ; STAT4 Transcription Factor - metabolism ; Time Factors ; Tissue Array Analysis ; transcriptio ; transduction ; Transfection ; Young Adult</subject><ispartof>World journal of gastroenterology : WJG, 2015-04, Vol.21 (13), p.3983-3993</ispartof><rights>The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. 2015</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-22d346c890a9a06d1de4fe130cc6ae60dfa37d5cfd2304bd5b54cdac09cb00523</citedby><cites>FETCH-LOGICAL-c440t-22d346c890a9a06d1de4fe130cc6ae60dfa37d5cfd2304bd5b54cdac09cb00523</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84123X/84123X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385547/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385547/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25852285$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Gang</creatorcontrib><creatorcontrib>Chen, Jia-Hui</creatorcontrib><creatorcontrib>Qiang, Yong</creatorcontrib><creatorcontrib>Wang, Dong-Zhi</creatorcontrib><creatorcontrib>Chen, Zhong</creatorcontrib><title>Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma</title><title>World journal of gastroenterology : WJG</title><addtitle>World Journal of Gastroenterology</addtitle><description>AIM: To investigate the role of signal transduction and activation of transcription 4(STAT4) in the development and progression of human hepatocellular carcinoma(HCC).METHODS: Recent genetic investigations have identified that a genetic variant of STAT4 is associated with hepatitis b virus(Hb V)-related HCC. The level of STAT4 in 90 HCC patients was examined via Western blot and immunohistochemical analyses. The correlation between STAT4 expression and the clinicopathological characteristics of the patients was analyzed. The level of STAT4 expression in the HCC liver tissues was significantly lower than that in the non-HCC liver tissues and correlated with tumor size, histological grade of HCC and serum hepatitis b surface antigen level in HCC patients. The data were statistically analyzed using SPSS. Furthermore, si RNA oligos targeting STAT4 were employed to investigate the influence of STAT4 RNA interference on HCC cell physiology. based on Cell Counting Kit-8 and flow cytometric assays, we found that depletion of STAT4 expression significantly enhanced the proliferation of L02 cells.RESULTS: STAT4 protein expression was significantly lower in HCC tissues than in normal liver tissues. Immunohistochemistry followed by statistical analysis revealed that the expression of STAT4 negatively correlated with Ki67 expression(r = 0.851; P &amp;lt; 0.05) and positively correlated with maximal tumor size(P &amp;lt; 0.05), Hb V(P = 0.012) and histological grade(P &amp;lt; 0.05). Kaplan-Meier analysis revealed significant differences in the survival curves between HCC patients expressing low and high levels of STAT4 and Ki67(P &amp;lt; 0.05). based on a multivariate Cox proportional hazard model, STAT4 expression was an independent prognostic indicator for HCC patients who underwent curative resection. In vitro, following the release of L02 cell lines from serum starvation, the expression of STAT4 was downregulated, and transfection of L02 cells with si RNA targeting STAT4 inhibited cell proliferation.CONCLUSION: Our data indicate that STAT4 may inhibit HCC development by modulating HCC cell proliferation.</description><subject>activation</subject><subject>Adult</subject><subject>Aged</subject><subject>and</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Carcinoma, Hepatocellular - genetics</subject><subject>Carcinoma, Hepatocellular - metabolism</subject><subject>Carcinoma, Hepatocellular - mortality</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Cell Proliferation</subject><subject>Chi-Square Distribution</subject><subject>Clinical Trials Study</subject><subject>Down-Regulation</subject><subject>Female</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Hep G2 Cells</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Kaplan-Meier Estimate</subject><subject>Ki-67 Antigen - metabolism</subject><subject>Liver Neoplasms - genetics</subject><subject>Liver Neoplasms - metabolism</subject><subject>Liver Neoplasms - mortality</subject><subject>Liver Neoplasms - pathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Neoplasm Grading</subject><subject>Proportional Hazards Models</subject><subject>Risk Factors</subject><subject>RNA Interference</subject><subject>Signal</subject><subject>Signal Transduction</subject><subject>STAT4 Transcription Factor - genetics</subject><subject>STAT4 Transcription Factor - metabolism</subject><subject>Time Factors</subject><subject>Tissue Array Analysis</subject><subject>transcriptio</subject><subject>transduction</subject><subject>Transfection</subject><subject>Young Adult</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkctvEzEQhy0EomnhzgntkcuG8WvXviBVLS-pEgfC2ZrY3o2rjZ3am1b893jVEIGlkQ-_hz36CHlHYc17oT4-3Y_rR0bXgfI114q_ICvGqG6ZEvCSrChA32rO-gtyWco9AONcstfkgkklGVNyRdytt9lj8a75ubneiCZEFyzOvjSHlHJzyGmMqYTSYHSNjzuMtnqtn6ZFm8LgM84hxRpsdv6Ac1q044S5sZhtiGmPb8irAafi357uK_Lry-fNzbf27sfX7zfXd60VAuaWMcdFZ5UG1Aido86LwVMO1nboO3AD8t5JOzjGQWyd3EphHVrQdgsgGb8in557D8ft3jvr45xxMocc9ph_m4TB_K_EsDNjejSCKylFXws-nApyejj6Mpt9KMs-GH06FkO7noEGDrRa4dlqcyol--H8DAWzwDEVjqlwTIVjFjg18v7f750Df2lUAz917lIcH0Iczx4NajlaglBCS16HCiVBCv4HCOGeWg</recordid><startdate>20150407</startdate><enddate>20150407</enddate><creator>Wang, Gang</creator><creator>Chen, Jia-Hui</creator><creator>Qiang, Yong</creator><creator>Wang, Dong-Zhi</creator><creator>Chen, Zhong</creator><general>Baishideng Publishing Group Inc</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150407</creationdate><title>Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma</title><author>Wang, Gang ; Chen, Jia-Hui ; Qiang, Yong ; Wang, Dong-Zhi ; Chen, Zhong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-22d346c890a9a06d1de4fe130cc6ae60dfa37d5cfd2304bd5b54cdac09cb00523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>activation</topic><topic>Adult</topic><topic>Aged</topic><topic>and</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Carcinoma, Hepatocellular - genetics</topic><topic>Carcinoma, Hepatocellular - metabolism</topic><topic>Carcinoma, Hepatocellular - mortality</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Cell Proliferation</topic><topic>Chi-Square Distribution</topic><topic>Clinical Trials Study</topic><topic>Down-Regulation</topic><topic>Female</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Hep G2 Cells</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Kaplan-Meier Estimate</topic><topic>Ki-67 Antigen - metabolism</topic><topic>Liver Neoplasms - genetics</topic><topic>Liver Neoplasms - metabolism</topic><topic>Liver Neoplasms - mortality</topic><topic>Liver Neoplasms - pathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Neoplasm Grading</topic><topic>Proportional Hazards Models</topic><topic>Risk Factors</topic><topic>RNA Interference</topic><topic>Signal</topic><topic>Signal Transduction</topic><topic>STAT4 Transcription Factor - genetics</topic><topic>STAT4 Transcription Factor - metabolism</topic><topic>Time Factors</topic><topic>Tissue Array Analysis</topic><topic>transcriptio</topic><topic>transduction</topic><topic>Transfection</topic><topic>Young Adult</topic><toplevel>online_resources</toplevel><creatorcontrib>Wang, Gang</creatorcontrib><creatorcontrib>Chen, Jia-Hui</creatorcontrib><creatorcontrib>Qiang, Yong</creatorcontrib><creatorcontrib>Wang, Dong-Zhi</creatorcontrib><creatorcontrib>Chen, Zhong</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Gang</au><au>Chen, Jia-Hui</au><au>Qiang, Yong</au><au>Wang, Dong-Zhi</au><au>Chen, Zhong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World Journal of Gastroenterology</addtitle><date>2015-04-07</date><risdate>2015</risdate><volume>21</volume><issue>13</issue><spage>3983</spage><epage>3993</epage><pages>3983-3993</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>AIM: To investigate the role of signal transduction and activation of transcription 4(STAT4) in the development and progression of human hepatocellular carcinoma(HCC).METHODS: Recent genetic investigations have identified that a genetic variant of STAT4 is associated with hepatitis b virus(Hb V)-related HCC. The level of STAT4 in 90 HCC patients was examined via Western blot and immunohistochemical analyses. The correlation between STAT4 expression and the clinicopathological characteristics of the patients was analyzed. The level of STAT4 expression in the HCC liver tissues was significantly lower than that in the non-HCC liver tissues and correlated with tumor size, histological grade of HCC and serum hepatitis b surface antigen level in HCC patients. The data were statistically analyzed using SPSS. Furthermore, si RNA oligos targeting STAT4 were employed to investigate the influence of STAT4 RNA interference on HCC cell physiology. based on Cell Counting Kit-8 and flow cytometric assays, we found that depletion of STAT4 expression significantly enhanced the proliferation of L02 cells.RESULTS: STAT4 protein expression was significantly lower in HCC tissues than in normal liver tissues. Immunohistochemistry followed by statistical analysis revealed that the expression of STAT4 negatively correlated with Ki67 expression(r = 0.851; P &amp;lt; 0.05) and positively correlated with maximal tumor size(P &amp;lt; 0.05), Hb V(P = 0.012) and histological grade(P &amp;lt; 0.05). Kaplan-Meier analysis revealed significant differences in the survival curves between HCC patients expressing low and high levels of STAT4 and Ki67(P &amp;lt; 0.05). based on a multivariate Cox proportional hazard model, STAT4 expression was an independent prognostic indicator for HCC patients who underwent curative resection. In vitro, following the release of L02 cell lines from serum starvation, the expression of STAT4 was downregulated, and transfection of L02 cells with si RNA targeting STAT4 inhibited cell proliferation.CONCLUSION: Our data indicate that STAT4 may inhibit HCC development by modulating HCC cell proliferation.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Inc</pub><pmid>25852285</pmid><doi>10.3748/wjg.v21.i13.3983</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1007-9327
ispartof World journal of gastroenterology : WJG, 2015-04, Vol.21 (13), p.3983-3993
issn 1007-9327
2219-2840
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4385547
source MEDLINE; Baishideng "World Journal of" online journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects activation
Adult
Aged
and
Biomarkers, Tumor - genetics
Biomarkers, Tumor - metabolism
Carcinoma, Hepatocellular - genetics
Carcinoma, Hepatocellular - metabolism
Carcinoma, Hepatocellular - mortality
Carcinoma, Hepatocellular - pathology
Cell Proliferation
Chi-Square Distribution
Clinical Trials Study
Down-Regulation
Female
Gene Expression Regulation, Neoplastic
Hep G2 Cells
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Ki-67 Antigen - metabolism
Liver Neoplasms - genetics
Liver Neoplasms - metabolism
Liver Neoplasms - mortality
Liver Neoplasms - pathology
Male
Middle Aged
Multivariate Analysis
Neoplasm Grading
Proportional Hazards Models
Risk Factors
RNA Interference
Signal
Signal Transduction
STAT4 Transcription Factor - genetics
STAT4 Transcription Factor - metabolism
Time Factors
Tissue Array Analysis
transcriptio
transduction
Transfection
Young Adult
title Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T21%3A19%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decreased%20STAT4%20indicates%20poor%20prognosis%20and%20enhanced%20cell%20proliferation%20in%20hepatocellular%20carcinoma&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Wang,%20Gang&rft.date=2015-04-07&rft.volume=21&rft.issue=13&rft.spage=3983&rft.epage=3993&rft.pages=3983-3993&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v21.i13.3983&rft_dat=%3Cproquest_pubme%3E1672090301%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1672090301&rft_id=info:pmid/25852285&rft_cqvip_id=90888889504849534951485054&rfr_iscdi=true